Anna Ivanenko
Sleep Medicine · Elk Grove Village, ILNPI 1255308334
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,712 of the $14,044 with a category attached, or 62.0%. Jazz Pharmaceuticals Inc. accounts for 72.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $10,743 and has fallen 97.6% since, to $260 in 2025.
Across 96 payments — averaging $146.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$10K
- Tris Pharma Inc$861
- Neos Therapeutics, LP$781
- Ironshore Pharmaceuticals Inc.$640
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$354
- Corium, LLC$237
- plus $937 from 16 others
What the payments were for
- Consulting fees$8,71262%
- Travel & lodging$9217%
- Food & beverage$4,41231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 18 | $10,235 |
| Tris Pharma Inc | 17 | $861 |
| Neos Therapeutics, LP | 8 | $781 |
| Ironshore Pharmaceuticals Inc. | 7 | $640 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $354 |
| Corium, LLC | 3 | $237 |
| Supernus Pharmaceuticals, Inc. | 2 | $224 |
| Boehringer Ingelheim | 6 | $112 |
| Axsome Therapeutics, Inc. | 1 | $94 |
| Harmony Biosciences LLC | 4 | $89 |
| Bayer | 6 | $82 |
| Actelion Pharmaceuticals US, Inc. | 4 | $73 |
| AstraZeneca | 4 | $66 |
| United Therapeutics Corporation | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Inogen, Inc. | 3 | $24 |
| Grifols USA, LLC | 1 | $22 |
| GSK | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 2 | $21 |
| UCB, Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$9,826
- Adzenys XR-ODT$765
- Dyanavel XR$473
- JORNAY PM$354
- CAPLYTA$354
- Quillichew ER$245
- Quillivant$245
- Azstarys$220
- QELBREE$125
- Jornay PM 20mg capsules (Bottle of 100)$116
- Cotempla XR-ODT$112
- Karbinal$112
How this compares
$14,044 in reported general payments places this provider in the 85th percentile of 79 sleep medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Temazepam | 13 | $164 |
| Amitriptyline Hcl | 12 | $146 |
| Sertraline Hcl | 17 | $124 |
| Clonazepam | 13 | $90 |
| Duloxetine Hcl | 19 | $76 |
| Bupropion Hcl SrBupropion Hcl | 15 | $56 |
| Zolpidem Tartrate | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Elk Grove Village
- Robert HartElk Grove Village$3K
- Muhammad NajjarNorthbrook$479K
- Phyllis ZeeChicago$214K
- Thomas FreedomGlenview$124K
- Syed SayeeduddinBrookfield$65K
- Hrayr AttarianChicago$43K
- Reena Dhanda-PatilChicago$41K
- Amy GuralnickChicago$19K
- Ahmer AliLake Barrington$15K
- Nawaid ShakirSchaumburg$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.